Molekulare Therapie neuroendokriner Neoplasien: Sunitinib (Sutent) und Everolimus (Afinetor).
Related Research units
Bibliographical data
Original language | German |
---|---|
Publication status | Published - 2014 |
Original language | German |
---|---|
Publication status | Published - 2014 |